- Home
- QUCY vs UG Comparison
QUCY vs UG Comparison
Compare QUCY & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QUCY | UG |
|---|---|---|
| Founded | 2008 | 1942 |
| Country | Germany | United States |
| Employees | 13 | N/A |
| Industry | | Package Goods/Cosmetics |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 36.5M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | QUCY | UG |
|---|---|---|
| Price | $1.11 | $7.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 5.7K |
| Earning Date | 06-26-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 7.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $10,545,468.00 |
| Revenue This Year | $74.34 | N/A |
| Revenue Next Year | $171.48 | N/A |
| P/E Ratio | ★ N/A | $38.80 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.30 | $5.58 |
| 52 Week High | $4.93 | $8.78 |
Technical Indicators
Market Signals| Indicator | QUCY | UG |
|---|---|---|
| Relative Strength Index (RSI) | 33.62 | 59.78 |
| Support Level | $0.38 | $6.89 |
| Resistance Level | $2.36 | $7.70 |
| Average True Range (ATR) | 0.10 | 0.20 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 5.68 | 49.14 |
Price Performance
Historical ComparisonAbout QUCY Mainz Biomed N.V. Ordinary Shares
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
About UG United-Guardian Inc.
United-Guardian Inc manufactures, markets and develops specialty cosmetic, personal care and sexual wellness ingredients, and a line of healthcare products including pharmaceuticals and medical lubricants. Its pharmaceutical products are distributed through national drug wholesalers to pharmacies, physicians, and hospitals. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. The company's majority of revenue is derived from the sales of Pharmaceuticals in the United States.